OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $789,000 Invested

2023

Esya Inc

Souvik Modi, PhD

ESYA AD360: A BLOOD-BASED DIAGNOSTIC PLATFORM FOR ALZHEIMER’S DISEASE DIAGNOSIS AND DIFFERENTIATE FROM OTHER COGNITIVE IMPAIRMENTS

  • Funding Amount: $789,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Other
  • Status: Active